BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23037927)

  • 1. Acute hemodynamic responses to supplemental oxygen and their prognostic implications in pulmonary hypertension.
    Leuchte HH; Baezner CJ; Baumgartner RA; Mernitz P; Neurohr C; Behr J
    Respiration; 2013; 85(5):400-7. PubMed ID: 23037927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of supplemental oxygen administration in an infant with pulmonary artery hypertension.
    Palmisano JM; Martin JM; Krauzowicz BA; Truman KH; Meliones JN
    Heart Lung; 1990 Nov; 19(6):627-30. PubMed ID: 2228653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension.
    Olsson KM; Frank A; Fuge J; Welte T; Hoeper MM; Bitter T
    Respir Res; 2015 Nov; 16():137. PubMed ID: 26538143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Apitz C; Hansmann G; Schranz D
    Heart; 2016 May; 102 Suppl 2():ii23-9. PubMed ID: 27053694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension with a low cardiac index requires a higher PaO
    Suda R; Tanabe N; Terada J; Naito A; Kasai H; Nishimura R; Sanada TJ; Sugiura T; Sakao S; Tatsumi K
    Respirology; 2020 Jan; 25(1):97-103. PubMed ID: 31099121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.
    Wang L; Zhao QH; Pudasaini B; Jiang R; Gong SG; He J; Yuan P; Liu JM
    Clin Respir J; 2018 Mar; 12(3):915-921. PubMed ID: 28026153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.
    Ghio S; D'Alto M; Badagliacca R; Vitulo P; Argiento P; Mulè M; Tuzzolino F; Scelsi L; Romeo E; Raineri C; Martino L; Tamburino C; Poscia R; Vizza CD
    Int J Cardiol; 2017 Mar; 230():53-58. PubMed ID: 28038821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Lorillon G; Jaïs X; Tcherakian C; Feuillet S; Dorfmüller P; Simonneau G; Humbert M; Tazi A
    Chest; 2012 Nov; 142(5):1150-1157. PubMed ID: 22459770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
    Ulrich S; Fischler M; Speich R; Popov V; Maggiorini M
    Chest; 2006 Sep; 130(3):841-6. PubMed ID: 16963684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics in pulmonary arterial hypertension: current and future perspectives.
    Saggar R; Sitbon O
    Am J Cardiol; 2012 Sep; 110(6 Suppl):9S-15S. PubMed ID: 22921033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in the course of diffuse parenchymal lung diseases - state of art and future considerations.
    Szturmowicz M; Kacprzak A; Błasińska-Przerwa K; Kuś J
    Pneumonol Alergol Pol; 2015; 83(4):312-23. PubMed ID: 26166793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic Thresholds for Precapillary Pulmonary Hypertension.
    Gerges C; Gerges M; Skoro-Sajer N; Zhou Y; Zhang L; Sadushi-Kolici R; Jakowitsch J; Lang MB; Lang IM
    Chest; 2016 Apr; 149(4):1061-73. PubMed ID: 26501411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic pulmonary hypertension: haemodynamic changes after oxygen and various vasodilators in the same patient at different time periods.
    Král H; Hamet A; Cernohorský D; Stásek J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):317-24. PubMed ID: 8599074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease: insights from a wireless pulmonary artery pressure monitoring system.
    Raina A; Abraham WT; Adamson PB; Bauman J; Benza RL
    J Heart Lung Transplant; 2015 Mar; 34(3):438-47. PubMed ID: 25813770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trends in the management of pulmonary hypertension associated with respiratory disease in institutions approved by the Japanese Respiratory Society.
    Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Miyaji K; Takamura K; Hayashi S; Hanaoka M; Tatsumi K;
    Respir Investig; 2014 May; 52(3):167-72. PubMed ID: 24853016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Rate and Oxygen Saturation Change Patterns During 6-min Walk Test in Subjects With Chronic Thromboembolic Pulmonary Hypertension.
    Inagaki T; Terada J; Yahaba M; Kawata N; Jujo T; Nagashima K; Sakao S; Tanabe N; Tatsumi K
    Respir Care; 2018 May; 63(5):573-583. PubMed ID: 29279364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.